Y-27632 2HCL

    產品編號: DC1028 Featured
    Y-27632 2HCL
    結構式
    129830-38-2
    此產品僅供科研所需,我們不出售給病人
    ?我們將匹配市場上最好的價格給您
    Email:order@dcbio.cn
    免費咨詢電話:4008862077
    我們的合作伙伴:
    • 20
    • 19
    • 18
    • 17
    • 16
    • 15
    • 14
    • 12
    • 11
    • 10
    • 9
    • 8
    • 13
    • 6
    • 5
    • 4
    • 3
    • 2
    • 1
    中國地區超過5000個高品質化合物庫存
    應用領域
    Y-27632 dihydrochloride 是口服有效的, ATP 競爭性的 ROCK-I 和 ROCK-II 抑制劑,Ki 分別為 220 nM 和 300 nM。Y-27632 dihydrochloride 誘導凋亡 (apoptosis)。Y-27632 dihydrochloride 通過上皮-間充質過渡樣調節引發人誘導多能干細胞 (hIPSCs) 選擇性地分化為間胚層譜系。
    Cas No.: 129830-38-2
    名稱: (1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride
    別名: Y-27632, Y27632, Y 27632
    SMILES: C[C@H](C1CCC(CC1)C(=O)NC2=CC=NC=C2)N.Cl.Cl
    分子式: C14H21N3O.2HCl
    分子量: 320.26
    純度:
    保存條件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
    Description:
    In Vivo:
    In Vitro:
    References: Y-27632 2Hcl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK. IC50 value: 140 nM (Ki) Target: ROCK1 in vitro: Y-27632 inhibits ROCK-II while displaying little activity against PKC, cAMP-dependent protein kinase and myosin light-chain kinase (MLCK) with Ki of 26 μM, 25 μM and > 250 μM, respectively, as well as PKA activated by another Rho-family GTPase member, Cdc42. Y-27632 inhibits smooth-muscle contraction induces by various agonists including phenylephrine, histamine, acetylcholine, serotonin, endothelin, and thromboxane with IC50 of 0.3-1 μM, by selectively inhibiting Ca2+ sensitization. Y-27632 suppresses Rho-induced, p160ROCK-mediated formation of stress fibres in cultured cells. In human embryonic stem (hES) cells, Y-27632 treatment at 10 μM markedly diminishes dissociation-induced apoptosis even in serum-free suspension (SFEB) culture, increases cloning efficiency (from ~1% to ~27%), facilitates subcloning after gene transfer, and enables SFEB-cultured hES cells to survive and differentiate into Bf1+ cortical and basal telencephalic progenitors. in vivo: Oral administration of Y-27632 at 30 mg/kg significantly decreases the blood pressure in a dose-dependent manner in spontaneous hypertensive rats, renal hypertensive rats, as well as deoxycorticosterone acetate (DOCA)-salt hypertensive rats. When Y-27632 is continuously administered at a rate of 0.55 μL per hour by implanted pumps for 11 days tumor cell invasion (MM1 cells expressing Val14-RhoA in rats) is significantly delayed. By inhibiting ROCK, Y-27632 treatment attenuates hypoxia-induced angiogenesis and vascular remodeling in the pulmonary circulation. For the detailed information about the solubility of Y-27632 2HCL in water, the solubility of Y-27632 2HCL in DMSO, the solubility of Y-27632 2HCL in PBS buffer, the animal experiment(test) of Y-27632 2HCL,the in vivo,in vitro and clinical trial test of Y-27632 2HCL,the cell experiment(test) of Y-27632 2HCL,the IC50, EC50 and Affinity of Y-27632 2HCL, please contact DC Chemicals.
    Kinase Assay:
    Cell Assay:
    Animal Administration:
    References:
    MSDS
    COA
    LOT NO. DOWNLOAD
    2018-0101
    產品編號 產品名稱 應用領域
    DC1028 Y-27632 2HCL Y-27632 dihydrochloride 是口服有效的, ATP 競爭性的 ROCK-I 和 ROCK-II 抑制劑,Ki 分別為 220 nM 和 300 nM。Y-27632 dihydrochloride 誘導凋亡 (apoptosis)。Y-27632 dihydrochloride 通過上皮-間充質過渡樣調節引發人誘導多能干細胞 (hIPSCs) 選擇性地分化為間胚層譜系。
    宝贝你的奶头好紧好大_宝贝你的小缝好紧好滑_宝贝你的胸好大好想吃